GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of VTGN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Weaker technical forecast for VistaGen Therapeutics Inc as stock downgraded to Sell Candidate.
(Updated on Apr 19, 2024)

Sell candidate since Apr 19, 2024 PDF

The VistaGen Therapeutics Inc stock price gained 1.28% on the last trading day (Friday, 19th Apr 2024), rising from $4.70 to $4.76. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 2.58% from a day low at $4.66 to a day high of $4.78. The price has risen in 6 of the last 10 days but is still down by -5.56% for this period. Volume fell on the last day by -41 thousand shares and in total, 152 thousand shares were bought and sold for approximately $724.02 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.58% during the next 3 months and, with a 90% probability hold a price between $3.76 and $5.23 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

VTGN Signals & Forecast

The VistaGen Therapeutics Inc stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $4.82. On a fall, the stock will find some support from the long-term average at approximately $4.65. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, April 02, 2024, and so far it has fallen -11.85%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for VistaGen Therapeutics Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $4.49 and $4.24. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, VistaGen Therapeutics Inc finds support just below today's level at $4.49. If this is broken, then the next support from accumulated volume will be at $4.24 and $4.17.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.120 between high and low, or 2.58%. For the last week the stock has had daily average volatility of 5.36%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VTGN) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect VistaGen Therapeutics Inc to open at $4.73, and during the day (based on 14 day Average True Range), to move between $4.45 and $5.07, which gives a possible trading interval of +/-$0.311 (+/-6.53%) up or down from last closing price. If VistaGen Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 13.06% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.85 (1.89%) than the support at $4.49 (5.67%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is VistaGen Therapeutics Inc stock A Buy?

VistaGen Therapeutics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -2.190 Sell Candidate Downgraded

Predicted Opening Price for VistaGen Therapeutics Inc of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$4.73 ( 0.560%) $4.76

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for VTGN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.85 1.96 %
R2 4.81 1.00 %
R1 4.78 0.403 %
Current price: 4.76
Support S1 4.69 -1.52 %
S2 4.66 -2.12 %
S3 4.61 -3.08 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.40 13.45 %
R2 5.28 10.92 %
R1 4.85 1.89 %
Current price 4.76
Support S1 4.49 -5.67%
S2 4.24 -11.03%
S3 4.17 -12.39%

FAQ

What is the symbol for VistaGen Therapeutics Inc Stock and on which exchange is it traded?
The symbol for VistaGen Therapeutics Inc is VTGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell VistaGen Therapeutics Inc Stock?
VistaGen Therapeutics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy VistaGen Therapeutics Inc Stock?
VistaGen Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy VistaGen Therapeutics Inc Stock.

What's the current price of VistaGen Therapeutics Inc Stock?
As of the end of day on the 2024-04-19, the price of an VistaGen Therapeutics Inc (VTGN) share was $4.76.

What is the 52-week high and low for VistaGen Therapeutics Inc Stock?
The 52-week high for VistaGen Therapeutics Inc Stock is $24.71 and the 52-week low is $1.62.

What is the market capitalization of VistaGen Therapeutics Inc Stock?
As of the 2024-04-19, the market capitalization of VistaGen Therapeutics Inc is 128.64M.

When is the next earnings date for VistaGen Therapeutics Inc?
The upcoming earnings date for VistaGen Therapeutics Inc is Jun 26, 2024.
Click to get the best stock tips daily for free!

About VistaGen Therapeutics Inc

VistaGen Therapeutics VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product... VTGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT